StockData
InMode Ltd. logo

InMode Ltd. (INMD) stock analysis

INMDNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 10, 2026Score 6/30
$13.19−0.54 (-3.93%)

Close on Nov 12, 2026Market cap $835.70MP/E 9.2Yield –

StockData Score

Prices as of Nov 11, 2026How the score works

Value0Growth0Performance1Health5Dividend0

Weak6 of 30 checks passed

InMode passes 6 of the 30 checks behind our score; 19 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
0/6
Growth
0/6
Past performance
1/6
Financial health
5/6
Dividend
0/6

What stands out

  • Return on capital over 10%

    Return on invested capital was 25.1%, above the 10% that usually covers the cost of capital.

  • No debt

    InMode has no borrowings on its latest balance sheet.

  • Interest well covered

    No meaningful interest expense to cover.

  • Debt covered by cash flow

    There is no debt to cover.

What to watch

  • Revenue growing under 10% a year

    Revenue grew -6.6% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing under 10% a year

    Diluted EPS grew -8.9% a year over the last three fiscal years.

  • Growing slower than the industry

    Revenue grew -6.2% over the last twelve months; the Surgical, Medical, and Dental Instruments and Supplies median is 11.0%.

  • Gross margin slipping

    Gross margin was 78.5% over the last twelve months, against 80.3% a year earlier.

Valuation0/6

  • P/E against its history

    Not enough price and earnings history to compare.

  • P/E against the industry

    Needs positive earnings and enough profitable companies in the industry.

  • EV/EBITDA against its history

    Needs positive EBITDA and price history.

  • P/B against the industry

    Needs positive book value.

  • Price against fair value

    We could not estimate a fair value: it needs at least two valuation methods with positive inputs.

  • Margin of safety

    Depends on the fair value estimate.

Growth0/6

  • Revenue growing under 10% a year

    Revenue grew -6.6% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing under 10% a year

    Diluted EPS grew -8.9% a year over the last three fiscal years.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing slower than the industry

    Revenue grew -6.2% over the last twelve months; the Surgical, Medical, and Dental Instruments and Supplies median is 11.0%.

  • Guidance issued

    The latest outlook (full year of 2026 Revenues, Feb 10, 2026) was issued for the first time, so it neither adds nor takes away points.

  • Gross margin slipping

    Gross margin was 78.5% over the last twelve months, against 80.3% a year earlier.

Past performance1/6

  • Return on equity

    Needs positive equity and five years of results.

  • Return on capital over 10%

    Return on invested capital was 25.1%, above the 10% that usually covers the cost of capital.

  • Return on equity against the industry

    Needs positive equity.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin against its history

    Needs five years of revenue and net income.

  • Net margin against the industry

    Needs revenue and net income.

Financial health5/6

  • No debt

    InMode has no borrowings on its latest balance sheet.

  • Debt not rising

    With no debt today, leverage cannot have risen.

  • Debt covered by cash flow

    There is no debt to cover.

  • Interest well covered

    No meaningful interest expense to cover.

  • Short-term assets cover short-term debts

    Current assets are 9.88 times current liabilities.

  • Bankruptcy risk (Altman Z)

    Needs market value, working capital and retained earnings.

Dividend0/6

  • No dividend

    InMode has not paid a dividend in the last twelve months.

  • Yield against Treasuries

    No dividend.

  • Yield against the market

    No dividend.

  • Dividend stability

    No dividend.

  • Earnings cover

    No dividend.

  • Cash-flow cover

    No dividend.

Scores of similar companies

Fair value

How we estimate it

We don't publish a fair value for InMode. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Medium risk

Average value traded per day
$7.73M
Value traded per 1% price move
$8.34M

Downside

Low risk

Typical loss in a bad month
12.5%
Volatility (annualized)
31%
Sharpe ratio, 1 year
-0.33
Beta to the S&P 500 (5Y)
1.43

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2016 to 2025

Gross margin

78.5%−6.5 pts over 5 years

Operating margin

23.0%−12.3 pts over 5 years

Net margin

–

See a number that looks wrong?